Leonteq Securities’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
Other funds holding TNXP
JHC
Leonteq Securities's TNXP Position: Q3 2026 in Review
Leonteq Securities sold out of Tonix Pharmaceuticals (TNXP) in Q3 2026, closing a stake of 5,700 shares — an estimated $72.7K sold.
Leonteq Securities first reported a position in TNXP in Q3 2025 and held it in 4 quarters. The position peaked at $89K in Q4 2025. 76 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.
- Leonteq Securities reported no remaining Tonix Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Leonteq Securities sold 5,700 Tonix Pharmaceuticals shares in Q3 2026, an estimated $72.7K.
- Leonteq Securities first reported a position in Tonix Pharmaceuticals in Q3 2025 and held it in 4 quarters.
- Leonteq Securities's Tonix Pharmaceuticals position peaked at $89K in Q4 2025.
- 76 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.